Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its ...

A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins are another fascinating aspect to the ...

Feds invest in AI for heart failure, vaccines and this year's midterms, and more health news from Morning Rounds ...

The two measles-related deaths in Pennsylvania last month involved infants, and the virus itself caused one of the deaths, a ...

A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in medicine.

In a pair of late-stage trials, an AstraZeneca drug reduced the dangerous flare-ups that worsen COPD, positioning it as a ...

ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial ...

Nothing in the recent reporting about John Fetterman is medically surprising,” write Michael P.H. Stanley and Isaiah Kletenik.

Rural health care providers, which have struggled for years, are facing nearly $1 trillion in Medicaid cuts over the coming ...

GOP candidates in Iowa and Florida are embracing vaccine skepticism, while Democrats in Michigan and South Carolina are ready for a fight.

For the past few months, key centers at the FDA have been led by acting officials. The agency said yesterday it will now make them permanent. Michael Davis will be director of the Center for Drug ...

WASHINGTON — The Trump administration permanently filled four key leadership roles at the Food and Drug Administration on ...